Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Sales (2016 - 2025)

Historic Return on Sales for Mimedx (MDXG) over the last 16 years, with Q2 2025 value amounting to 0.0%.

  • Mimedx's Return on Sales changed 0.0% to 0.0% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.0%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 300.0% up from last year.
  • Mimedx's Return on Sales amounted to 0.0% in Q2 2025, which was down 0.0% from 0.0% recorded in Q1 2025.
  • Mimedx's Return on Sales' 5-year high stood at 0.13% during Q4 2022, with a 5-year trough of 0.18% in Q1 2022.
  • For the 5-year period, Mimedx's Return on Sales averaged around 0.04%, with its median value being 0.0% (2023).
  • Per our database at Business Quant, Mimedx's Return on Sales skyrocketed by 2600bps in 2021 and then crashed by -1400bps in 2022.
  • Quarter analysis of 5 years shows Mimedx's Return on Sales stood at 0.0% in 2021, then skyrocketed by 3275bps to 0.13% in 2022, then crashed by -81bps to 0.03% in 2023, then crashed by -95bps to 0.0% in 2024, then plummeted by -51bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q2 2025, 0.0% for Q1 2025, and 0.0% during Q4 2024.